The Incidence of Urticaria, Angioedema, and Type I Hypersensitivity Reactions with Fibrinolytic Agents in Thailand Using Health Product Vigilance Center Database
Not Applicable
Completed
- Conditions
- The aim of study was to analyze the incidence of urticaria angioedema and type I hypersensitivity reactions from fibrinolytic agents in various indicationsanaphylaxis,hypotension,streptokinase,tenecteplase,tissue plasminogen activator
- Registration Number
- TCTR20191030004
- Lead Sponsor
- Faculty of Pharmacy, Silpakorn University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 284
Inclusion Criteria
All reports of urticaria, angioedema, or type I hypersensitivity reactions caused due to streptokinase, alteplase, and TNK were enrolled, and any reports described as “unlikely†based on Naranjo probability scale was excluded. Terms specified in the spontaneous reporting system according to the WHO adverse reaction terminology (WHO-ART) were used for identifying the reactions
Exclusion Criteria
No data about important
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of allergy 5 years Incidence
- Secondary Outcome Measures
Name Time Method /A N/A N/A